VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
Clinical trial NCT04796012 · RECRUITING
Trial details
- NCT number
- NCT04796012
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-18
- Primary completion
- 2027-01-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.